190 related articles for article (PubMed ID: 25824984)
1. Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.
Hou X; Wu X; Huang P; Zhan J; Zhou T; Ma Y; Qin T; Luo R; Feng Y; Xu Y; Chen L; Zhang L
Int J Cancer; 2015 Oct; 137(7):1672-8. PubMed ID: 25824984
[TBL] [Abstract][Full Text] [Related]
2. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
Zhang L; Hou X; Lu S; Rao H; Hou J; Luo R; Huang H; Zhao H; Jian H; Chen Z; Liao M; Wang X
Lung Cancer; 2010 Jan; 67(1):114-9. PubMed ID: 19376608
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of bone sialoprotein in clear cell renal carcinoma.
Righi L; Bollito E; Ceppi P; Mirabelli D; Tavaglione V; Chiusa L; Porpiglia F; Brunelli M; Martignoni G; Terrone C; Papotti M
Anticancer Res; 2013 Jun; 33(6):2679-87. PubMed ID: 23749927
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
[TBL] [Abstract][Full Text] [Related]
5. Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.
Wu G; Guo JJ; Ma ZY; Wang J; Zhou ZW; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2010-7. PubMed ID: 25973097
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease.
Wang HH; Wang XW; Tang CE
J Cancer Res Ther; 2011; 7(2):138-42. PubMed ID: 21768699
[TBL] [Abstract][Full Text] [Related]
7. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
[TBL] [Abstract][Full Text] [Related]
8. Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.
Kruger TE; Miller AH; Godwin AK; Wang J
Crit Rev Oncol Hematol; 2014 Feb; 89(2):330-41. PubMed ID: 24071501
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.
Xu L; Fan S; Zhao J; Zhou P; Chu S; Luo J; Wen Q; Chen L; Wen S; Wang L; Shi L
Diagn Pathol; 2017 Jan; 12(1):2. PubMed ID: 28061788
[TBL] [Abstract][Full Text] [Related]
10. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
11. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
Cao X; Han Y; He L; Xiang J; Wen Z
Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.
Carlinfante G; Vassiliou D; Svensson O; Wendel M; Heinegård D; Andersson G
Clin Exp Metastasis; 2003; 20(5):437-44. PubMed ID: 14524533
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
[TBL] [Abstract][Full Text] [Related]
15. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of primary gross tumor volume and standardized uptake value of
Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
[TBL] [Abstract][Full Text] [Related]
17. LOX expression in primary nasopharyngeal carcinoma: correlation with prognostic parameters and outcome.
Hua YJ; Wang HY; Tang LQ; Chen QY; Shao JY; Mai HQ
Oncotarget; 2016 Feb; 7(7):8200-7. PubMed ID: 26882568
[TBL] [Abstract][Full Text] [Related]
18. Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma.
Lu X; Qian CN; Mu YG; Li NW; Li S; Zhang HB; Li SW; Wang FL; Guo X; Xiang YQ
Eur J Cancer; 2011 Feb; 47(3):339-46. PubMed ID: 20951575
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy.
Lu T; Guo Q; Cui X; Chen Z; Lin S; Xu L; Lin J; Zong J; Pan J
Yonsei Med J; 2016 Jul; 57(4):840-5. PubMed ID: 27189275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
